Lv2
136 积分 2022-12-15 加入
Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis
4小时前
待确认
Vascular Cognitive Impairment and Dementia
4天前
已完结
Transferrin receptor–targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA
3个月前
已完结
From geroscience to precision geromedicine: Understanding and managing aging
3个月前
已完结
CSF LRRK2: A biomarker for slower autonomic dysfunction progression in sporadic Parkinson's disease
4个月前
已关闭
Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide
5个月前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
6个月前
已完结
Trends in First‐in‐Human Studies for Intrathecal Antisense Oligonucleotides: Insights From 2010 to 2024
7个月前
已完结
Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series
8个月前
已完结
Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series
8个月前
已完结
皖公网安备34019202002308
